Cargando…

Identification of patients with congenital hemophilia in a large electronic health record database

BACKGROUND: Electronic health records (EHRs) are an important source of information with regard to diagnosis and treatment of rare health conditions, such as congenital hemophilia, a bleeding disorder characterized by deficiency of factor VIII (FVIII) or factor IX (FIX). OBJECTIVE: To identify patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Michael, Cyhaniuk, Anissa, Cooper, David L, Iyer, Neeraj N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5587134/
https://www.ncbi.nlm.nih.gov/pubmed/28919830
http://dx.doi.org/10.2147/JBM.S133616
_version_ 1783261942658367488
author Wang, Michael
Cyhaniuk, Anissa
Cooper, David L
Iyer, Neeraj N
author_facet Wang, Michael
Cyhaniuk, Anissa
Cooper, David L
Iyer, Neeraj N
author_sort Wang, Michael
collection PubMed
description BACKGROUND: Electronic health records (EHRs) are an important source of information with regard to diagnosis and treatment of rare health conditions, such as congenital hemophilia, a bleeding disorder characterized by deficiency of factor VIII (FVIII) or factor IX (FIX). OBJECTIVE: To identify patients with congenital hemophilia using EHRs. DESIGN: An EHR database study. SETTING: EHRs were accessed from Humedica between January 1, 2007, and July 31, 2013. PATIENTS: Selection criteria were applied for an initial ICD-9-CM diagnosis of 286.0 (hemophilia A) or 286.1 (hemophilia B), and confirmation of records 6 months before and 12 months after the first diagnosis. Additional selection criteria included mention of “hemophilia” and “blood” or “bleed” within physician notes identified via natural language processing. RESULTS: A total of 129 males and 35 females were identified as the analysis population. Of those patients for whom both prothrombin time and activated partial thromboplastin time test results were available, only 56% of males and 7% of females exhibited a pattern of test results consistent with congenital hemophilia (normal prothrombin time and prolonged activated partial thromboplastin time). Few patients had a prescription for a hemophilia treatment; males most commonly received Amicar (10.8%) or FVIII (9.0%), whereas females most commonly received DDAVP (11.0%). The most identifiable sites of pain were the chest and the abdomen; 41% of males and 37% of females had joint pain. To evaluate whether patients had been correctly identified with congenital hemophilia, EHRs of 6 patients were reviewed; detailed assessment of their data was found to be inconsistent with a conclusive diagnosis of congenital hemophilia. LIMITATIONS: Inconsistent coding practices may affect data integrity. CONCLUSION: A potentially high number of false positive identifications, particularly among female patients, suggests that ICD-9-CM coding alone may be insufficient to identify patient cohorts. In-depth reviews and multimodal analysis of chart notes may improve data integrity.
format Online
Article
Text
id pubmed-5587134
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-55871342017-09-15 Identification of patients with congenital hemophilia in a large electronic health record database Wang, Michael Cyhaniuk, Anissa Cooper, David L Iyer, Neeraj N J Blood Med Original Research BACKGROUND: Electronic health records (EHRs) are an important source of information with regard to diagnosis and treatment of rare health conditions, such as congenital hemophilia, a bleeding disorder characterized by deficiency of factor VIII (FVIII) or factor IX (FIX). OBJECTIVE: To identify patients with congenital hemophilia using EHRs. DESIGN: An EHR database study. SETTING: EHRs were accessed from Humedica between January 1, 2007, and July 31, 2013. PATIENTS: Selection criteria were applied for an initial ICD-9-CM diagnosis of 286.0 (hemophilia A) or 286.1 (hemophilia B), and confirmation of records 6 months before and 12 months after the first diagnosis. Additional selection criteria included mention of “hemophilia” and “blood” or “bleed” within physician notes identified via natural language processing. RESULTS: A total of 129 males and 35 females were identified as the analysis population. Of those patients for whom both prothrombin time and activated partial thromboplastin time test results were available, only 56% of males and 7% of females exhibited a pattern of test results consistent with congenital hemophilia (normal prothrombin time and prolonged activated partial thromboplastin time). Few patients had a prescription for a hemophilia treatment; males most commonly received Amicar (10.8%) or FVIII (9.0%), whereas females most commonly received DDAVP (11.0%). The most identifiable sites of pain were the chest and the abdomen; 41% of males and 37% of females had joint pain. To evaluate whether patients had been correctly identified with congenital hemophilia, EHRs of 6 patients were reviewed; detailed assessment of their data was found to be inconsistent with a conclusive diagnosis of congenital hemophilia. LIMITATIONS: Inconsistent coding practices may affect data integrity. CONCLUSION: A potentially high number of false positive identifications, particularly among female patients, suggests that ICD-9-CM coding alone may be insufficient to identify patient cohorts. In-depth reviews and multimodal analysis of chart notes may improve data integrity. Dove Medical Press 2017-08-30 /pmc/articles/PMC5587134/ /pubmed/28919830 http://dx.doi.org/10.2147/JBM.S133616 Text en © 2017 Wang et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Wang, Michael
Cyhaniuk, Anissa
Cooper, David L
Iyer, Neeraj N
Identification of patients with congenital hemophilia in a large electronic health record database
title Identification of patients with congenital hemophilia in a large electronic health record database
title_full Identification of patients with congenital hemophilia in a large electronic health record database
title_fullStr Identification of patients with congenital hemophilia in a large electronic health record database
title_full_unstemmed Identification of patients with congenital hemophilia in a large electronic health record database
title_short Identification of patients with congenital hemophilia in a large electronic health record database
title_sort identification of patients with congenital hemophilia in a large electronic health record database
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5587134/
https://www.ncbi.nlm.nih.gov/pubmed/28919830
http://dx.doi.org/10.2147/JBM.S133616
work_keys_str_mv AT wangmichael identificationofpatientswithcongenitalhemophiliainalargeelectronichealthrecorddatabase
AT cyhaniukanissa identificationofpatientswithcongenitalhemophiliainalargeelectronichealthrecorddatabase
AT cooperdavidl identificationofpatientswithcongenitalhemophiliainalargeelectronichealthrecorddatabase
AT iyerneerajn identificationofpatientswithcongenitalhemophiliainalargeelectronichealthrecorddatabase